Foggi P - Search Results

1

High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.

Vici P, Capomolla E, Foggi P, Carpano S, Conti F, Paoletti G, Cauchi C, Giacinti L, Leonetti C, Giannarelli D, Lopez M. Vici P, et al. Among authors: foggi p. J Exp Clin Cancer Res. 2006 Mar;25(1):39-44. J Exp Clin Cancer Res. 2006. PMID: 16761616

2

Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.

Vici P, Foggi P, Colucci G, Capomolla E, Brandi M, Giotta F, Gebbia N, Di Lauro L, Valerio MR, Paoletti G, Belli F, Pizza C, Giannarelli D, Lopez M. Vici P, et al. Among authors: foggi p. Anticancer Res. 2005 Mar-Apr;25(2B):1309-14. Anticancer Res. 2005. PMID: 15865083 Free article. Clinical Trial.

3

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M. Vici P, et al. Among authors: foggi p. Anticancer Res. 2009 May;29(5):1841-5. Anticancer Res. 2009. PMID: 19443414 Free article. Clinical Trial.

4

Docetaxel in patients with anthracycline-resistant advanced breast cancer.

Vici P, Belli F, Di Lauro L, Amodio A, Conti F, Foggi P, Gionfra T, Morelli MF, Botti C, Ferraironi A, Lopez M. Vici P, et al. Among authors: foggi p. Oncology. 2001;60(1):60-5. doi: 10.1159/000055298. Oncology. 2001. PMID: 11150910 Clinical Trial.

5

[New combination chemotherapy regimens in the primary treatment of operable breast cancer].

Conti F, Sergi D, Foggi P, Abbate MI, Lopez M. Conti F, et al. Among authors: foggi p. Clin Ter. 2007 Jan-Feb;158(1):55-75. Clin Ter. 2007. PMID: 17405660 Review. Italian.

6

[Role of adjuvant chemotherapy in the choice of chemotherapeutic treatment of metastatic breast cancer].

Lopez M, Di Lauro L, Viola G, Conti F, Foggi P, Vici P. Lopez M, et al. Among authors: foggi p. Clin Ter. 2009;160(6):489-97. Clin Ter. 2009. PMID: 20198293 Italian.

7

A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.

Vici P, Di Lauro L, Sergi D, Foggi P, Viola G, Mottolese M, Giotta F, Fattoruso SI, Corsetti S, Giannarelli D, Botti C, Lopez M. Vici P, et al. Among authors: foggi p. Oncology. 2008;75(3-4):175-81. doi: 10.1159/000163056. Epub 2008 Oct 8. Oncology. 2008. PMID: 18841031 Clinical Trial.

8

[Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma].

Amodio A, Carpano S, Paoletti G, Gionfra T, Rinaldi M, Manfredi C, Foggi P, Lopez M. Amodio A, et al. Among authors: foggi p. Clin Ter. 1998 Mar-Apr;149(2):121-5. Clin Ter. 1998. PMID: 9780476 Clinical Trial. Italian.

9

Single-agent ifosfamide in the treatment of anthracycline-refractory adult sarcomas.

Lopez M, Carpano S, Amodio A, Gionfra T, Della Giulia M, Foggi P, Manfredi C, Del Monte G. Lopez M, et al. Among authors: foggi p. Clin Ter. 1998 Sep-Oct;149(5):331-3. Clin Ter. 1998. PMID: 10052244 Clinical Trial.

10

[Chemotherapy of advanced stage melanoma using cisplatin, epirubicin and alpha-interferon].

Carpano S, Amodio A, Bucher S, Foggi P, Vici P, Rinaldi M, Mariotti S, Del Monte G, Lopez M. Carpano S, et al. Among authors: foggi p. Clin Ter. 1999 Mar-Apr;150(2):109-14. Clin Ter. 1999. PMID: 10396859 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters